These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 26317853)
1. Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study. Shafiei SS; Solati-Hashjin M; Samadikuchaksaraei A; Kalantarinejad R; Asadi-Eydivand M; Abu Osman NA PLoS One; 2015; 10(8):e0136530. PubMed ID: 26317853 [TBL] [Abstract][Full Text] [Related]
2. Facile synthesis of camptothecin intercalated layered double hydroxide nanohybrids via a coassembly route. Wu X; Li H; Song S; Zhang R; Hou W Int J Pharm; 2013 Sep; 454(1):453-61. PubMed ID: 23820133 [TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia. Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064 [TBL] [Abstract][Full Text] [Related]
4. Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach. Yuan X; He Y; Zhou G; Li X; Feng A; Zheng W J Photochem Photobiol B; 2018 Jun; 183():147-153. PubMed ID: 29705507 [TBL] [Abstract][Full Text] [Related]
5. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272 [TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells. Hagen RM; Chedea VS; Mintoff CP; Bowler E; Morse HR; Ladomery MR Int J Oncol; 2013 Jul; 43(1):194-200. PubMed ID: 23615977 [TBL] [Abstract][Full Text] [Related]
7. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796 [TBL] [Abstract][Full Text] [Related]
8. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate. Ray L; Kumar P; Gupta KC Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370 [TBL] [Abstract][Full Text] [Related]
9. The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids. Qin L; Wang M; Zhu R; You S; Zhou P; Wang S Int J Nanomedicine; 2013; 8():2053-64. PubMed ID: 23737669 [TBL] [Abstract][Full Text] [Related]
10. Preparation and antibacterial activity of lysozyme and layered double hydroxide nanocomposites. Yang QZ; Chang YY; Zhao HZ Water Res; 2013 Nov; 47(17):6712-8. PubMed ID: 24053938 [TBL] [Abstract][Full Text] [Related]
11. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft. Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231 [TBL] [Abstract][Full Text] [Related]
12. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. Sanna V; Pintus G; Roggio AM; Punzoni S; Posadino AM; Arca A; Marceddu S; Bandiera P; Uzzau S; Sechi M J Med Chem; 2011 Mar; 54(5):1321-32. PubMed ID: 21306166 [TBL] [Abstract][Full Text] [Related]
13. Facile synthesis of methotrexate intercalated layered double hydroxides: particle control, structure and bioassay explore. Tian DY; Liu ZL; Li SP; Li XD Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():297-305. PubMed ID: 25491832 [TBL] [Abstract][Full Text] [Related]
14. Controlled release of organic-inorganic nanohybrid:cefadroxil intercalated Zn-Al-layered double hydroxide. Khan SB; Alamry KA; Alyahyawi NA; Asiri AM Int J Nanomedicine; 2018; 13():3203-3222. PubMed ID: 29881273 [TBL] [Abstract][Full Text] [Related]
15. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482 [TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062 [TBL] [Abstract][Full Text] [Related]
17. In vitro controlled release of vitamin C from Ca/Al layered double hydroxide drug delivery system. Gao X; Chen L; Xie J; Yin Y; Chang T; Duan Y; Jiang N Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():56-60. PubMed ID: 24863197 [TBL] [Abstract][Full Text] [Related]
18. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery. Xu T; Zhang J; Chi H; Cao F Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970 [TBL] [Abstract][Full Text] [Related]
19. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Hsieh DS; Wang H; Tan SW; Huang YH; Tsai CY; Yeh MK; Wu CJ Biomaterials; 2011 Oct; 32(30):7633-40. PubMed ID: 21782236 [TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]